• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
FIXX

FIXX

Homology Medicines, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.93

+0.01 (+0.77%)

Company Profile

CEO

Paul Alloway

IPO Date

2018-03-28

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.92

Prev. Close

$0.93

Day Low

$0.90

Day High

$0.97

52W Low

$0.90

52W High

$26.64

Market Cap

$0.00B

Volume

0.40M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

55.1%

Avg Negative

1.2%

Avg Neutral

43.5%

News Feed

Homology Medicines Reports First Quarter 2021 Financial Results and Recent Highlights

GlobeNewsWire·5/6/2021·↑ positive

Homology Medicines Announces Presentations at ACMG Annual Clinical Genetics Meeting

GlobeNewsWire·4/14/2021·↑ positive

Homology Medicines Announces Promotion of Tim Kelly to Chief Operating Officer

GlobeNewsWire
·4/12/2021
·↑ positive

Why Homology Medicines Stock Is Sinking Today

The Motley Fool·4/7/2021·↑ positive

Homology Medicines Announces Pricing of Public Offering of Common Stock

GlobeNewsWire·4/7/2021·↑ positive

Homology Medicines Announces Proposed Public Offering of Common Stock

GlobeNewsWire·4/6/2021·↑ positive

Homology Medicines Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights

GlobeNewsWire·3/11/2021·↑ positive

Homology Medicines Regains Worldwide Rights to Ophthalmology Program Based on its In Vivo Nuclease-Free Gene Editing Platform

GlobeNewsWire·3/1/2021·↑ positive

Homology Medicines Announces First Presentation of Data with HMI-203 In Vivo Gene Therapy Development Candidate for Hunter Syndrome

GlobeNewsWire·2/8/2021·↑ positive

Homology Medicines Reports Third Quarter 2020 Financial Results and Recent Highlights

GlobeNewsWire·11/9/2020·↑ positive